Cebiotex S.L.

Paediatric oncology

Clinical research includes treatment settings for children and adolescents with solid tumours, with attention to difficult-to-treat abdominal and paediatric malignancies.

  • Neuroblastoma
  • Wilms tumour
  • Germ cell tumour
  • Desmoplastic small round cell tumour

The sponsor’s portfolio also extends to rare childhood cancers that require specialised oncological care and localised surgical management.

Soft tissue sarcoma and retroperitoneal cancer

Research activity is concentrated in sarcoma care, particularly disease affecting the retroperitoneum and other soft-tissue sites.

  • Soft-tissue sarcoma
  • Synovial sarcoma
  • Recurrent or locally advanced retroperitoneal soft tissue sarcoma
  • Extracranial malignant rhabdoid tumour

These studies reflect an interest in aggressive tumours with limited therapeutic options and a need for local disease control.

Abdominal solid tumours and hepatopancreatic oncology

The sponsor funds trials in malignant disease of the abdomen, including cancers arising in the pancreas and liver.

  • Pancreatic carcinoma
  • Fibrolamellar hepatocellular carcinoma
  • Locally resectable abdominal tumours

Research in this area covers complex solid tumours where anatomical location and surgical context are central to clinical management.

Rare and high-risk solid tumours

Additional trial activity is directed toward uncommon and biologically aggressive cancers across paediatric and adult oncology.

  • High-risk neuroblastoma
  • Germ cell tumour
  • Desmoplastic small round cell tumour
  • Extracranial malignant rhabdoid tumour

This includes malignancies marked by rapid progression, rarity, and a need for specialised therapeutic approaches.

Local therapy-focused oncology

The sponsor’s research is centred on tumours managed in conjunction with surgery, with interest in post-operative and locally advanced disease.

  • Post-surgical recurrence
  • Locally advanced solid tumours
  • Abdominal tumour resection

Trial activity is aligned with oncology settings where local tumour control and recurrence prevention are key clinical concerns.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Tolerability of CEB-01 in Patients with Pancreatic Cancer

    Recruiting

    2 1 1
    Investigated diseases:
    Spain
  • Study on the Safety and Effectiveness of CEB-01 for Children with Resectable Tumors

    Not yet recruiting

    2 1 1
    Spain